IMMUNITYBIO, INC. Diluted Shares Outstanding (Weighted Average)
IMMUNITYBIO, INC. (IBRX) reported Diluted Shares Outstanding (Weighted Average) of 1.05 billion shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-04
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.05B shares, a 18.22% increase year-over-year.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.03B shares, a 20.36% increase year-over-year.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 990.45M shares, a 34.76% increase year-over-year.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 946.60M shares, a 35.62% increase year-over-year.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 919.86M shares, a 31.33% increase from fiscal 2024.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 700.44M shares, a 37.71% increase from fiscal 2023.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 508.64M shares, a 27.19% increase from fiscal 2022.
- IMMUNITYBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 399.90M shares, a 2.74% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.05B shares 10-Q · filed 2026-08-04 | 1.04B shares 10-Q · filed 2026-08-04 | 1.02B shares derived: average of 3 quarters · filed 2026-08-04 | 1.00B shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | 1.03B shares 10-Q · filed 2026-05-07 | 1.01B shares derived: average of 2 quarters · filed 2026-05-07 | 987.97M shares derived: average of 3 quarters · filed 2026-05-07 | 963.03M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | 990.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 968.52M shares derived: average of 2 quarters · filed 2026-02-23 | 941.75M shares derived: average of 3 quarters · filed 2026-08-04 | 919.86M shares 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | 946.60M shares 10-Q · filed 2025-11-05 | 917.41M shares derived: average of 2 quarters · filed 2026-08-04 | 896.34M shares 10-Q · filed 2025-11-05 | 855.73M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | 888.22M shares 10-Q · filed 2026-08-04 | 870.79M shares 10-Q · filed 2026-08-04 | 825.44M shares derived: average of 3 quarters · filed 2026-08-04 | 793.57M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | 853.16M shares 10-Q · filed 2026-05-07 | 794.06M shares derived: average of 2 quarters · filed 2026-05-07 | 762.03M shares derived: average of 3 quarters · filed 2026-05-07 | 743.25M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 734.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 716.46M shares derived: average of 2 quarters · filed 2026-02-23 | 706.62M shares derived: average of 3 quarters · filed 2026-02-23 | 700.44M shares 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | 697.96M shares 10-Q · filed 2025-11-05 | 692.45M shares derived: average of 2 quarters · filed 2025-11-05 | 688.94M shares 10-Q · filed 2025-11-05 | 681.82M shares derived: average of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | 686.94M shares 10-Q · filed 2025-08-05 | 686.94M shares 10-Q · filed 2024-08-12 | 679.88M shares 10-Q · filed 2025-08-05 | 679.88M shares 10-Q · filed 2024-08-12 | 676.44M shares derived: average of 3 quarters · filed 2026-02-23 | 631.93M shares derived: average of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | 672.83M shares 10-Q · filed 2025-05-12 | 672.83M shares 10-Q · filed 2024-05-09 | 671.20M shares derived: average of 2 quarters · filed 2026-02-23 | 613.59M shares derived: average of 3 quarters · filed 2026-02-23 | 569.56M shares derived: average of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | 669.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 583.97M shares derived: average of 2 quarters · filed 2026-02-23 | 535.13M shares derived: average of 3 quarters · filed 2026-02-23 | 508.64M shares 10-K · filed 2026-02-23 | 508.64M shares 10-K · filed 2024-03-19 | |||
| 2023-09-30 | 498.38M shares 10-Q · filed 2024-11-12 | 498.38M shares 10-Q · filed 2023-11-09 | 467.92M shares derived: average of 2 quarters · filed 2024-11-12 | 454.99M shares 10-Q · filed 2024-11-12 | 454.99M shares 10-Q · filed 2023-11-09 | 441.96M shares derived: average of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | 437.46M shares 10-Q · filed 2024-08-12 | 432.94M shares 10-Q · filed 2024-08-12 | 423.16M shares derived: average of 3 quarters · filed 2025-03-03 | 417.39M shares derived: average of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | 428.38M shares 10-Q · filed 2024-05-09 | 416.01M shares derived: average of 2 quarters · filed 2025-03-03 | 410.69M shares derived: average of 3 quarters · filed 2025-03-03 | 407.52M shares derived: average of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | 403.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 401.85M shares derived: average of 2 quarters · filed 2025-03-03 | 400.56M shares derived: average of 3 quarters · filed 2025-03-03 | 399.90M shares 10-K · filed 2025-03-03 | 399.90M shares 10-K · filed 2023-03-01 | |||
| 2022-09-30 | 400.06M shares 10-Q · filed 2023-11-09 | 399.03M shares derived: average of 2 quarters · filed 2023-11-09 | 398.65M shares 10-Q · filed 2023-11-09 | 398.26M shares derived: average of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | 397.99M shares 10-Q · filed 2023-08-08 | 397.94M shares 10-Q · filed 2023-08-08 | 397.66M shares derived: average of 3 quarters · filed 2024-03-19 | 396.21M shares derived: average of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | 397.88M shares 10-Q · filed 2023-05-11 | 397.50M shares derived: average of 2 quarters · filed 2024-03-19 | 395.62M shares derived: average of 3 quarters · filed 2024-03-19 | 392.92M shares derived: average of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | 397.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 394.49M shares derived: average of 2 quarters · filed 2024-03-19 | 391.26M shares derived: average of 3 quarters · filed 2024-03-19 | 389.23M shares 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | 391.85M shares 10-Q · filed 2022-11-09 | 388.34M shares derived: average of 2 quarters · filed 2022-11-09 | 386.61M shares 10-Q · filed 2022-11-09 | 385.39M shares derived: average of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | 384.82M shares 10-Q · filed 2022-08-08 | 383.94M shares 10-Q · filed 2022-08-08 | 383.24M shares derived: average of 3 quarters · filed 2023-03-01 | 382.87M shares derived: average of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | 382.74M shares 10-Q · filed 2022-05-10 | 382.45M shares derived: average of 2 quarters · filed 2023-03-01 | 382.22M shares derived: average of 3 quarters · filed 2023-03-01 | |||||
| 2020-12-31 | 382.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 381.96M shares derived: average of 2 quarters · filed 2023-03-01 | 377.07M shares 10-K · filed 2023-03-01 | |||||
| 2020-09-30 | 381.76M shares 10-Q · filed 2021-11-12 | 375.37M shares 10-Q · filed 2021-11-12 | ||||||
| 2019-12-31 | 366.32M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |